7/15/2013
Girls with Guns (gwg)
Hmmm. It may be that there are two kinds of photos of "girls with guns", from here after referred to as (GWG,gwg). One is sexist and subordinates the female body to an extension of objectivity for the male aesthetic (sex/violence). The other is a gwg that empowers women to find their own aesthetic or political enfranchisement through the basic human right to own an assault rifle. There are what I would consider subversive meme generators who are 70% good and 30% bad when they should be 100% good and 0% bad.
Subscribe to:
Post Comments (Atom)
GSK's targeted melanoma drugs approved by EU Tafinlar expected
ReplyDeleteGlaxoSmithKline's Tafinlar (dabrafenib) in obtaining European CHMP recommended the listing after entering the European market is expected to become the second BRAF inhibitors. Tafinlar being considered as a model for the BRAF V600 mutation advanced (unresectable or metastatic) melanoma treatment of adult patients.
Tafinlar is an oral formulation of this medication shown to delay progression of the disease, compared with the chemotherapy drug dacarbazine can improve response rates. European Medicines Agency (EMA) Committee for Medicinal Products for human use (CHMP) positive evaluation on Tafinlar drugs can make this with Roche's Weiluofeini (vemurafinib) parallel competition Weiluofeini EU marketing approval last year.
Metastatic melanoma patients, approximately half of the patients whose protein kinase BRAF mutation, and BRAF V600E mutation can account for about 80% to 90%. These mutations result in cells produce a protein irregular promote tumor growth, while blocking Weiluofeini Tafinlar and it is this irregularity proteins to help slow the growth and spread of tumors. Such individualized drug therapy in melanoma field represents an important therapeutic advances over the past decades for the treatment of this disease mainly around cytotoxic chemotherapy and immunotherapy.
Melanoma is the sixth largest male, female seventh most common cancer in Europe every year about 60,000 newly diagnosed cases. Skin Melanoma Melanoma is the most common form, is the most aggressive form of skin cancer, in patients with stage IV melanoma, the average survival period of about 6 months. This year in May, Tafinlar received FDA approval in the United States, and now the Committee for Medicinal Products for human use would recommend this drug in the three-month time period to obtain the approval of the European Commission.
Medchemexpress Can provide the above product,its website:www.medchemexpress.com
BS-181
SB1317
NVP-LCQ195
Roscovitine
PD 0332991
AT7519
AT7519 hydrochloride
CVT-313
LY2603618
CCT241533